Loredana Alletto is the Chief Operating Officer of Regensight. She will lead the strategies and operations of Regensight, consistently with the objective of affirming the new paradigm of theranostics for predictive and precision treatment of keratoconu ...
Elevating the standard of care to patients starts from the beginning of project development and the real understanding of eye doctors needs. We at Regensight are meeting this challenge and transforming eye doctors experience in treating keratoconus using ...
The ARGO clinical trial protocol has been published in the “New Treatments for Keratoconus” Special Issue of International Ophthalmology. The publication is open access and available at https://link.springer.com/article/10.1007/s10792-022-02628-4. T ...
Pleased to end this amazing year with the honor to see our most recent publication on theranostics on the cover of Journal of Biophotonics. The article is open access and available at https://onlinelibrary.wiley.com/doi/10.1002/jbio.202200218. Theranost ...
The Mario Lombardo award has been assigned to Dr. Raffaella Gioia, a young ophthalmologist recently specialized at the Magna Graecia University of Catanzaro. The celebration was held at the Regensight Research & Development Lab. in Reggio C ...
We are pleased to award the "Mario Lombardo" Research Prize to Dr. Raffaella Gioia, who ha been recently specialized in Ophthalmology at the Magna Graecia University of Catanzaro. We at Regensight award the commitment of Raffaella to the study and mana ...
Glad to promote the Mario Lombardo Research Award. The award will be assigned to a young research devoted to the research & development of new methods and techniques for the prevention, diagnosis and treatment of keratoconus. For more information ...
A new scientific research was recently published in the prestigious Journal of Biophotonics. The study shows the pre-clinical efficacy results of the innovative theranostic-guided corneal cross-linking procedure for the treatment of keratoconus. The s ...
Regensight announces that a new research & development unit has been established in the metropolitan city of Reggio calabria and that it will be active from 1 September 2022. The laboratory, strongly desired by the co-founders, was created to stren ...
We are pleased to announce the start of the multicenter randomized clinical trial aiming at assessing theranostic-guided corneal cross-linking for treatment of keratoconus. The clinical trial is conducted at three of the major Italian Universities devo ...
